28.06.2019 Views

Gauteng Business 2019-20 edition

The 2019/20 edition of Gauteng Business is the 11th issue of this highly successful publication that has established itself as the premier business and investment guide for the Gauteng Province. In addition to the regular articles providing insight into each of the key economic sectors of the province, there are special features on ambitious plans to re-imagine the central business district of Johannesburg, a trend in urban development that is growing across the province, and on the impact of renewable energy in urban settings. The Gauteng Growth and Development Agency outlines its priorities and showcases the success of the OR Tambo Special Economic Zone in these pages. Subscribe for monthly updates here: https://www.globalafricanetwork.com/subscribe/

The 2019/20 edition of Gauteng Business is the 11th issue of this highly successful publication that has established itself as the premier business and investment guide for the Gauteng Province.

In addition to the regular articles providing insight into each of the key economic sectors of the province, there are special features on ambitious plans to re-imagine the central business district of Johannesburg, a trend in urban development that is growing across the province, and on the impact of renewable energy in urban settings. The Gauteng Growth and Development Agency outlines its priorities and showcases the success of the OR Tambo Special Economic Zone in these pages. Subscribe for monthly updates here: https://www.globalafricanetwork.com/subscribe/

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

OVERVIEW<br />

Pharmaceuticals<br />

A licence to make a biosimilar drug has been granted.<br />

SECTOR HIGHLIGHTS<br />

Pharmacy Direct has spent<br />

R100-million on a warehouse<br />

upgrade.<br />

South Africa has one of the world’s biggest HIV/Aids<br />

programmes. The National Department of Health’s<br />

Centralised Chronic Medicines Dispensing and Distribution<br />

programme aims to reach six-million patients on treatment<br />

by <strong>20</strong>21. It is currently serving 4.4-million patients.<br />

In mid-<strong>20</strong>18 Pharmacy Direct, an Afrocentric business based<br />

in Centurion, spent R100-million on upgrading a warehouse for<br />

distributing medicines to state patients. This sector is likely to grow<br />

if the state goes ahead with plans for National Health Insurance. The<br />

NHI intends to create a single fund that will buy services on behalf of<br />

all South Africans.<br />

The National Association of Pharmaceutical Manufacturers (NAPM)<br />

has re-branded as Generic and Biosimilar Medicines of Southern Africa.<br />

A new field opened up in the pharmaceutical industry when the<br />

South African Health Products Regulatory Authority (SAHPRA) gave<br />

ONLINE RESOURCES<br />

Centre for Advanced Manufacturing: www.cfam.co.za<br />

Chemical and Allied Industries’ Association: www.caia.co.za<br />

Generic and Biosimilar Medicines of Southern Africa:<br />

http://gbmsa.or<br />

National Health Insurance: www.health.gov.za/index.php/nhi<br />

the go-ahead for the production of<br />

a biosimilar drug in July <strong>20</strong>18, the<br />

first time this has been allowed in<br />

South Africa. Teva Pharmaceutical<br />

Industries became the first<br />

company to win a licence with<br />

their version of Amgen’s filgrastim,<br />

a white blood cell booster.<br />

South Africa’s pharmaceutical<br />

sector is worth approximately R<strong>20</strong>-<br />

billion annually. Although there are<br />

more than <strong>20</strong>0 pharmaceutical<br />

firms in the country, large<br />

companies dominate the field,<br />

with Aspen Pharmacare (34%)<br />

and Adcock Ingram (25%) the two<br />

key players, followed by Sanofi,<br />

Pharmaplan and Cipla Medpro.<br />

Among the other big<br />

international brands active in<br />

<strong>Gauteng</strong> are Merck, which has a<br />

55 000m² plant at Modderfontein,<br />

and Pfizer SA, which runs a<br />

laboratory in Sandton amongst its<br />

facilities in South Africa. Adcock<br />

Ingram is building a new steriles<br />

plant for ophthalmic products at<br />

its Clayville facility.<br />

The private sector accounts for<br />

80% of pharmaceutical industry<br />

sales by value and <strong>20</strong>% by volume,<br />

while this ratio is reversed in the<br />

case of the public sector.<br />

GAUTENG BUSINESS <strong><strong>20</strong>19</strong>/<strong>20</strong><br />

42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!